How can traditional Chinese medicine increase the competitiveness of plant extracts or drive deep processing

With the "return to nature" and "green consumption" becoming more and more fashionable in recent years, plant extract, as the main raw material of modern plant medicine preparation, integrates modern pharmaceutical technology and becomes the core product in the market of natural medicine health care products, cosmetics, food, tobacco and other industries The huge market space makes plant extract become a hot product in the international market As early as 2007, the global plant medicine market has a scale of 70 billion US dollars, and has maintained an annual growth rate of 10% - 20% Plant extracts in China are mainly the deep processing of traditional Chinese medicine, which has the characteristics of less investment in development, high technology content, high added value of products and wide international market In addition, China's plant extract industry is guided by traditional Chinese medicine theory, and has unique development advantages World famous manufacturers of plant medicine, health care products and cosmetics are all interested in plant extracts in China Bayer, Amway, Roche, Novartis, Estee Lauder, ASMA, DSM, Rohm Haas and other multinational giants are common buyers of plant extracts in China As a large category of commodities in the import and export trade of traditional Chinese medicine, plant extracts have developed rapidly in recent years In 2008, the total export volume of plant extracts increased from 126 million US dollars in 2000 to 530 million US dollars in 2008, more than quadrupled, ranking first in the export volume of traditional Chinese medicine products From January to February 2009, the export volume of plant extracts reached US $88.412 million, an increase of 21.5% year on year, accounting for 48.5% of the total export volume of traditional Chinese medicine products, showing the most dazzling performance in the export products of traditional Chinese medicine Therefore, plant extracts are expected to be the main driving force and engine to promote the export of traditional Chinese medicine products Although the development of Chinese plant extract enterprises is in good condition, we should also see our own problems, and have a sense of suffering and a long-term goal In short board China, there are many problems in plant extraction industry, such as small industrial scale and low economic benefit According to incomplete statistics, there are more than 2000 plant extract production enterprises in China, but few large-scale production enterprises Among the 1130 export enterprises of plant extract products, only 91 enterprises export more than US $1 million The entry threshold of plant extract industry is not high, which leads to the confusion and vicious competition of industry development In recent years, some small enterprises have joined in the industry, and often compete with low-cost and poor quality products This not only disrupts the domestic market order, but also weakens the international competitiveness of China's plant extract products It is reported that in the mid-1990s, Ginkgo biloba extract was highly profitable, and its raw material market price was once as high as $375 / kg Now, Ginkgo biloba extract has fallen to the bottom of $35 / kg, less than 1 / 10 of the original price, and a large number of single product companies are out Lack of innovation awareness and intellectual property protection is also a major concern for the domestic plant extraction industry The plant extract industry should be a high-tech and high value-added industry based on innovative research and development However, at present, some domestic small enterprises mainly imitate Once a product is popular in the international market, a large number of enterprises will soon follow up If the industry lacks independent innovation, it lacks the power of sustainable development However, large plant extract enterprises lack brand awareness and intellectual property protection, which reduces their competitiveness in the international market How should China's plant extraction industry deal with its own problems? First of all, it is urgent to change the development strategy of the enterprise, extend the industrial chain, move closer to the end products such as botanical drugs, health care products, biopesticides and botanical veterinary drugs, and change from the raw material suppliers of plant extracts to the manufacturers of finished products, so as to improve their own strength and economic benefits The way out for Chinese plant extract enterprises in the future is to get involved in the manufacturing of terminal products, and first grab a place in the local market of China, which is the consensus of the industry The government should also pay attention to regulating the access mechanism of plant extract industry and strengthen the qualification examination of production enterprises Secondly, the state should encourage the merger and reorganization of enterprises through market means from the perspective of policies, form a group of influential large enterprises in the industry, increase the voice of the international market, and maintain the healthy and orderly development of the industry In addition, domestic plant extract manufacturers should strengthen the protection of intellectual property rights, establish brand awareness and maintain their own brand image.